173 related articles for article (PubMed ID: 22428754)
1. Matrix metalloproteinase-2, -9, -12, and tissue inhibitor of metalloproteinase 2 gene polymorphisms and cutaneous expressions in patients with Behçet's disease.
Park KS; Min Y; Park SR; Kim EH; Lee DJ; Bang D; Lee ES
Tissue Antigens; 2012 May; 79(5):333-9. PubMed ID: 22428754
[TBL] [Abstract][Full Text] [Related]
2. Association of MMP-9 gene polymorphisms with Behçet's disease risk.
Naouali A; Kaabachi W; Tizaoui K; Amor AB; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Mar; 164(1):18-24. PubMed ID: 25639450
[TBL] [Abstract][Full Text] [Related]
3. MMP-2, MMP-9 and TIMP-2 gene polymorphisms in Chinese patients with generalized aggressive periodontitis.
Chen D; Wang Q; Ma ZW; Chen FM; Chen Y; Xie GY; Wang QT; Wu ZF
J Clin Periodontol; 2007 May; 34(5):384-9. PubMed ID: 17448043
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
[TBL] [Abstract][Full Text] [Related]
5. Association between matrix metalloproteinase 9 promoter polymorphisms and Behçet's disease.
Lee YJ; Kang SW; Baek HJ; Choi HJ; Bae YD; Kang EH; Lee EY; Lee EB; Song YW
Hum Immunol; 2010 Jul; 71(7):717-22. PubMed ID: 20363273
[TBL] [Abstract][Full Text] [Related]
6. Matrix Metalloproteinase-9 rs17576 Gene Polymorphism and Behçet's Disease: Is There an Association?
Kamal A; Elgengehy FT; Abd Elaziz MM; Gamal SM; Sobhy N; Medhat A; El Dakrony AHM
Immunol Invest; 2017 Jul; 46(5):460-468. PubMed ID: 28388268
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis.
Kang S; Zhao X; Xing H; Wang N; Zhou R; Chen S; Li W; Zhao J; Duan Y; Sun D; Li Y
Environ Mol Mutagen; 2008 Apr; 49(3):226-31. PubMed ID: 18288718
[TBL] [Abstract][Full Text] [Related]
8. Role of MMP-2, MMP-7, MMP-9 and TIMP-2 in the development of recurrent depressive disorder.
Bobińska K; Szemraj J; Czarny P; Gałecki P
J Affect Disord; 2016 Nov; 205():119-129. PubMed ID: 27434116
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer.
Park KS; Kim SJ; Kim KH; Kim JC
J Gastroenterol Hepatol; 2011 Feb; 26(2):391-7. PubMed ID: 21261731
[TBL] [Abstract][Full Text] [Related]
10. Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas.
Coven İ; Ozer O; Ozen O; Şahin Fİ; Altinors N
J Neurosurg; 2014 Dec; 121(6):1478-82. PubMed ID: 25259564
[TBL] [Abstract][Full Text] [Related]
11. The GC + CC genotype at position -418 in TIMP-2 promoter and the -1575GA/-1306CC genotype in MMP-2 is genetic predisposing factors for prevalence of moyamoya disease.
Park YS; Jeon YJ; Kim HS; Han IB; Oh SH; Kim DS; Kim NK
BMC Neurol; 2014 Oct; 14():180. PubMed ID: 25280484
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
[TBL] [Abstract][Full Text] [Related]
13. Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer.
Sharma KL; Misra S; Kumar A; Mittal B
Liver Int; 2012 Sep; 32(8):1278-86. PubMed ID: 22621753
[TBL] [Abstract][Full Text] [Related]
14. Association between polymorphisms of FCRL3, a non-HLA gene, and Behçet's disease in a Chinese population with ophthalmic manifestations.
Li K; Zhao M; Hou S; Du L; Kijlstra A; Yang P
Mol Vis; 2008; 14():2136-42. PubMed ID: 19050767
[TBL] [Abstract][Full Text] [Related]
15. Analysis of MMP-9 and TIMP-2 gene promoter polymorphisms in individuals with hypodontia.
Peres RC; Line SR
Braz Dent J; 2005; 16(3):231-6. PubMed ID: 16429190
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis.
de Souza AP; Trevilatto PC; Scarel-Caminaga RM; de Brito RB; Barros SP; Line SR
J Clin Periodontol; 2005 Feb; 32(2):207-11. PubMed ID: 15691353
[TBL] [Abstract][Full Text] [Related]
17. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
[TBL] [Abstract][Full Text] [Related]
18. [Association of SNPs in the promoter of MMP-2 and TIMP-2 genes with epithelial ovarian cancer].
Li XL; Kang S; Zhao XW; Zhang XJ; Zhou RM; Wang N; Jia JH; Zhao J; Li Y
Yi Chuan; 2008 Apr; 30(4):455-62. PubMed ID: 18424416
[TBL] [Abstract][Full Text] [Related]
19. Association of macrophage migration inhibitory factor gene polymorphisms with Behçet's disease in a Han Chinese population.
Zheng X; Wang D; Hou S; Zhang C; Lei B; Xiao X; Kijlstra A; Yang P
Ophthalmology; 2012 Dec; 119(12):2514-8. PubMed ID: 22939113
[TBL] [Abstract][Full Text] [Related]
20. Association of Polymorphisms of the Tissue Inhibitors of Metalloproteinases- 1 and -2 with Alzheimer's Disease in Taiwan.
Ho WM; Lee YS; Chen CM; Wu YY; Hsu WC; Huang YH; Chen YC
Curr Alzheimer Res; 2021; 18(6):505-512. PubMed ID: 34561981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
